World's Best Scientists 2026 revealed!
Gabriela Riemekasten

Gabriela Riemekasten

D-Index & Metrics

Immunology

D-Index
73
Citations
28052
World Ranking
2089
National Ranking
144

Overview

Gabriela Riemekasten is affiliated with the University of Lübeck in Germany and has contributed extensively to the field of medicine, with a focus on specialty areas such as pathology and forensic medicine, immunology, pulmonary and respiratory medicine, rheumatology, and molecular biology.

Their research predominantly centers on systemic sclerosis and related diseases, alongside significant work in interstitial lung diseases and idiopathic pulmonary fibrosis. Other major topics include mast cells and histamine, dermatologic treatments and research, inflammatory myopathies and dermatomyositis, urticaria and related conditions, and systemic lupus erythematosus research.

Frequent co-authors in their publications include Harald Heidecke, Elise Siegert, Oliver Distler, Peter Lamprecht, and Jens Y. Humrich, indicating ongoing collaboration within their research community.

Gabriela Riemekasten has published regularly in several venues notable for rheumatology and immunology research. These include:

  • Annals of the Rheumatic Diseases (30 publications)
  • Lara D. Veeken (15 publications)
  • Frontiers in Immunology (13 publications)
  • Zeitschrift für Rheumatologie (11 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (9 publications)

Significant papers authored or co-authored cover clinical trials and disease mechanisms, reflecting a range of emphases within systemic sclerosis and related inflammatory conditions. Selected recent publications include:

  • "Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial," 2020, The Lancet Respiratory Medicine
  • "Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database," 2020, Annals of the Rheumatic Diseases
  • "Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases," 2021, Frontiers in Immunology
  • "Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases," 2022, Frontiers in Medicine
  • "Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity," 2022, Nature Communications

The depth and breadth of Gabriela Riemekasten's scholarship, including 352 publications broadly in medicine, underscore a consistent focus on both clinical and molecular aspects of autoimmune and inflammatory diseases. Their work often intersects the diverse fields of rheumatology and pulmonary medicine, contributing data relevant to disease mechanisms and therapeutic approaches.

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Anthony J. Tyndall;Bettina Bannert;Madelon Vonk;Paolo Airò

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    Dinesh Khanna;Christopher P Denton;Angelika Jahreis;Jacob M van Laar

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Mechanisms of Autoantibody-Induced Pathology.

    Ralf J. Ludwig;Karen Vanhoorelbeke;Frank Leypoldt;Ziya Kaya

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Florian M P Meier;Klaus W Frommer;Robert Dinser;Ulrich A Walker

  • Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

    Katharina Hanke;Claudia S Brückner;Cornelia Dähnrich;Dörte Huscher

  • Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

    Gabriela Riemekasten;Aurélie Philippe;Melanie Näther;Torsten Slowinski

  • Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

    Caroline von Spee-Mayer;Elise Siegert;Dimas Abdirama;Angelika Rose

  • Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.

    Anna-Maria Hoffmann-Vold;Yannick Allanore;Margarida Alves;Cathrine Brunborg

  • Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

    Veronika K. Jaeger;Elina G. Wirz;Yannick Allanore;Philipp Rossbach

  • Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells.

    Giuliana Cassese;Steffi Lindenau;Bauke de Boer;Sergio Arce

  • Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

    Dinesh Khanna;Christopher P Denton;Celia J F Lin;Jacob M van Laar

  • Sialic acid–binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

    Robert Biesen;Robert Biesen;Cemal Demir;Fidan Barkhudarova;Fidan Barkhudarova;Joachim R. Grün

  • Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

    Maureen D. Mayes;Lara Bossini-Castillo;Olga Gorlova;José Ezequiel Martin

  • The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.

    N. Hunzelmann;E. Genth;T. Krieg;W. Lehmacher

  • Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study

    Muriel Elhai;Marine Meunier;Marco Matucci-Cerinic;Britta Maurer

Frequent Co-Authors

Christopher P. Denton
Christopher P. Denton University College London
Yannick Allanore
Yannick Allanore Université Paris Cité
Oliver Distler
Oliver Distler University of Zurich
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Ariane L. Herrick
Ariane L. Herrick University of Manchester
Paolo Airò
Paolo Airò University of Brescia
Ulf Müller-Ladner
Ulf Müller-Ladner University of Giessen
Falk Hiepe
Falk Hiepe Charité - University Medicine Berlin
Jörg H W Distler
Jörg H W Distler University of Erlangen-Nuremberg
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens diverse career opportunities in healthcare and research. Many students interested in applying their immunology knowledge pursue nursing degrees to work closely with patient care and advanced clinical practice.

For those without a nursing background, online RN programs for non nurses offer accessible pathways to become registered nurses. These programs balance theory and clinical skills, often with flexible schedules to accommodate working professionals.

If you're looking for a quicker route into nursing, exploring accelerated nursing programs can fast-track your career advancement. These programs build on existing academic experience to prepare students for nursing licensure efficiently.

For those interested in foundational nursing roles, the easiest LPN programs to get into provide entry-level opportunities with shorter duration and focused practical training. This can be a stepping stone towards more advanced qualifications.

Additionally, becoming a family nurse practitioner is an excellent way to specialize in patient care, and the easiest FNP program options highlight accessible routes to enter this advanced practice field, where immunology expertise is highly valuable.

Best Scientists Citing Gabriela Riemekasten

Trending Scientists